From: Biological roles of RNA m5C modification and its implications in Cancer immunotherapy
m5C regulators | Position | Function | Potential mechanism | Refs |
---|---|---|---|---|
ALYREF, NSUN5, DNMT1 | HNSCC | Participate in progress and predict prognosis | Involved in regulating tumor energy metabolism and protein synthesis | [90] |
NSUN2 | Gastric Cancer | Cell Proliferation | Regulate downstream gene p57Kip2 | [98] |
NSUN2 | HDFs | Cell Proliferation and Senescence | Regulate the expression of p27 and CDK1 | [99] |
NSUN2 | U87 | Cell Migration | Participate in regulation by methylating ATX mRNA | [100] |
NSUN2 | HCC | Cell Differentiation | Recruit oncoprotein G3BP1 | [95] |
NSUN2, ALYREF | Bladder Cancer | Cell Proliferation and Migration | Regulation of mRNA stability through a new binding protein YBX1 in the cytoplasm | [31] |
NSUN6 | Pancreatic Cancer | Cell Proliferation | Regulates cell cycle and G2M checkpoints | [101] |
NSUN4, ALYREF | HCC | Tumor progression | High expression of NSUN4 and ALYREF is significantly correlated with survival outcome | [94] |
NSUN2, NSUN6 | TNBC | Tumor proliferation Occurrence and Metastasis. | Affect tumor development and tumor immune microenvironment | [102] |
NSUN2 | Gastrointestinal Cancer | Tumor progression and pathological staging | Regulates GSK3B and participates in the ErbB/PI3K-Akt signaling pathway | [103] |
DNMT3A | Glioblastoma Multiforme | Tumor progression | Inhibit the formation of miRNA/mRNA duplexes, loss of tumor suppression kinetic energy | [104] |
ALYREF | Bladder Cancer | Glycolysis and Tumorigenesis | Overexpression of ALYREF promotes the proliferation of bladder cancer cells through PKM2-mediated glycolysis. | [105] |